Immunogenetics of prostate cancer: a still unexplored field of study.

作者: Eva Dreussi , Fabrizio Ecca , Lucia Scarabel , Sara Gagno , Giuseppe Toffoli

DOI: 10.2217/PGS-2017-0163

关键词:

摘要: The immune system is a double-edged sword with regard to the prostate cancer (PCa) battle. Immunogenetics, study of potential role immune-related polymorphisms, taking its first steps in treatment this malignancy. This review summarizes most recent papers addressing immunogenetics PCa, reporting polymorphisms associated tumor aggressiveness, toxicity and patients' prognosis. With some peculiarities, RNASEL, IL-6, IL-10, IL-1β MMP7 have arisen as significant biomarkers PCa management, having clinical role. Validation prospective studies are required translate into precision PCa.

参考文章(133)
T. Langsenlehner, E.-M. Thurner, W. Renner, A. Gerger, K.S. Kapp, U. Langsenlehner, Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy. Strahlentherapie Und Onkologie. ,vol. 190, pp. 364- 369 ,(2014) , 10.1007/S00066-013-0503-2
Gilberto Vargas-Alarcón, Miguel Cruz-López, Adán Valladares, Edith Álvarez-León, Teresa Juárez-Cedillo, Óscar Pérez-Méndez, Jorge Escobedo de-la-Peña, Galileo Escobedo, Jose Manuel Fragoso, The interleukin-1β-511 T>C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients. Immunology Letters. ,vol. 168, pp. 7- 12 ,(2015) , 10.1016/J.IMLET.2015.08.005
Giulio Cabrini, Simonetta Falzoni, Sylvia L Forchap, Patrizia Pellegatti, Alessandra Balboni, Paola Agostini, Antonio Cuneo, Gianluigi Castoldi, O Roberto Baricordi, Francesco Di Virgilio, None, A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. Journal of Immunology. ,vol. 175, pp. 82- 89 ,(2005) , 10.4049/JIMMUNOL.175.1.82
Soyoung A. Oh, Ming O. Li, TGF-β: Guardian of T Cell Function Journal of Immunology. ,vol. 191, pp. 3973- 3979 ,(2013) , 10.4049/JIMMUNOL.1301843
Samaher Besbes, Massoud Mirshahi, Marc Pocard, Christian Billard, New dimension in therapeutic targeting of BCL-2 family proteins Oncotarget. ,vol. 6, pp. 12862- 12871 ,(2015) , 10.18632/ONCOTARGET.3868
Qian Sun, Xian Zhao, Xin Liu, Yanli Wang, Jian Huang, Bing Jiang, Qin Chen, Jianxiu Yu, miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. The Prostate. ,vol. 74, pp. 1613- 1621 ,(2014) , 10.1002/PROS.22878
Li Xue, Xiujuan Han, Rongrong Liu, Ziming Wang, Hecheng Li, Qi Chen, Peng Zhang, Zhenlong Wang, Tie Chong, MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer Oncotarget. ,vol. 7, pp. 31825- 31831 ,(2016) , 10.18632/ONCOTARGET.3923
Danielle M. Karyadi, Shanshan Zhao, Qianchuan He, Laura McIntosh, Jonathan L. Wright, Elaine A. Ostrander, Ziding Feng, Janet L. Stanford, Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families International Journal of Cancer. ,vol. 136, pp. 2166- 2171 ,(2015) , 10.1002/IJC.29241
Anna Solini, Vittorio Simeon, Lisa Derosa, Paola Orlandi, Chiara Rossi, Andrea Fontana, Luca Galli, Teresa Di Desidero, Anna Fioravanti, Sara Lucchesi, Luigi Coltelli, Laura Ginocchi, Giacomo Allegrini, Romano Danesi, Alfredo Falcone, Guido Bocci, Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients. Oncotarget. ,vol. 6, pp. 28743- 28754 ,(2015) , 10.18632/ONCOTARGET.4926
Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, Helen K Angell, Anne Berger, Christine Lagorce, Alessandro Lugli, Inti Zlobec, Arndt Hartmann, Carlo Bifulco, Iris D Nagtegaal, Richard Palmqvist, Giuseppe V Masucci, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Michele Maio, Luigi Laghi, Fabio Grizzi, Martin Asslaber, Corrado D'Arrigo, Fernando Vidal‐Vanaclocha, Eva Zavadova, Lotfi Chouchane, Pamela S Ohashi, Sara Hafezi‐Bakhtiari, Bradly G Wouters, Michael Roehrl, Linh Nguyen, Yutaka Kawakami, Shoichi Hazama, Kiyotaka Okuno, Shuji Ogino, Peter Gibbs, Paul Waring, Noriyuki Sato, Toshihiko Torigoe, Kyogo Itoh, Prabhu S Patel, Shilin N Shukla, Yili Wang, Scott Kopetz, Frank A Sinicrope, Viorel Scripcariu, Paolo A Ascierto, Francesco M Marincola, Bernard A Fox, Franck Pagès, None, Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. The Journal of Pathology. ,vol. 232, pp. 199- 209 ,(2014) , 10.1002/PATH.4287